Biotech

In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Novocure Ltd. (NASDAQ:NVCR), reported that Pomona Capital Vii, L.p. has picked up 9,874,860 of common stock as of 2017-03-23. The acquisition brings the aggregate amount owned by Pomona Capital Vii, L.p. to a total of...

In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Therapeuticsmd Inc. (NYSEMKT:TXMD) reported that Smith Robert J has picked up 12,157,505 of common stock as of 2017-03-22. The acquisition brings the aggregate amount owned by Smith Robert J to a total of 12,157,505 representing...

In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Cutera Inc. (NASDAQ:CUTR) reported that Voce Capital has picked up 477,031 of common stock as of 2017-03-22. The acquisition brings the aggregate amount owned by Voce Capital to a total of 477,031 representing a 3.4%...

In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Radius Health Inc. (NASDAQ:RDUS) reported that Bb Biotech Ag has picked up 4,718,922 of common stock as of 2017-03-22. The acquisition brings the aggregate amount owned by Bb Biotech Ag to a total of 4,718,922...

Some of the biggest biotechnology winners of 2017 so far are cannabis stocks. GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH), a $3 billion pharmaceutical cannabis company and probably the most well known company in this subsector of healthcare, is up around 7% since the start of the year. Zynerba Pharmaceuticals Inc...